Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cellular profiling identifies targetable T cell phenotypes in lymphocytic variant hypereosinophilic syndrome
Kristy Tefft, … , Brett King, Jaehyuk Choi
Kristy Tefft, … , Brett King, Jaehyuk Choi
Published November 3, 2025
Citation Information: J Clin Invest. 2025;135(21):e190853. https://doi.org/10.1172/JCI190853.
View: Text | PDF
Research Letter Dermatology Immunology

Cellular profiling identifies targetable T cell phenotypes in lymphocytic variant hypereosinophilic syndrome

  • Text
  • PDF
Abstract

Authors

Kristy Tefft, Amy Wang, Zachary Z. Reinstein, Yue Zhang, Arundhati Pillai, Sunghee Hwang, Spencer Ng, Raymond J. Cho, Jeffrey B. Cheng, Fei Li Kuang, Brett King, Jaehyuk Choi

×

Figure 1

CD3–CD4+ lymphocytes are unique Th2-like cells and express targetable surface markers and cytokines.

Options: View larger image (or click on image) Download as PowerPoint
CD3–CD4+ lymphocytes are unique Th2-like cells and express targetable su...
(A) Images of patients 3 and 4. (B) UMAPs of CD4-gated cells aggregated from all samples (n = 6) grouped/colored as indicated. Reg/mem, regulatory/memory. (C) Top 5 clonotypes per sample by cell number. (D) Volcano plot of differentially expressed genes between LHES-associated CD3–CD4+ versus atlas Th2 memory-like cells (Padj < 0.05). (E) Heatmap of SCENIC regulons of naive CD4+ cells and CD3–CD4+ clusters from patients with LHES, atlas Th2 memory-like cells. (F) CellChat analysis among CD3–CD4+ T cells. (G) Absolute blood CD3–CD4+ T cell count in patient 4. (H) Patient 3 clinical course timeline; CTNNB1/STAT3 variant maps. Bar chart of posttreatment variant prevalence confirmed with amplicon DNA sequencing.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts